Results 151 to 160 of about 72,003 (276)

Markers of kidney tubule dysfunction and injury and long-term risk of acute kidney injury following coronary artery bypass graft surgery. [PDF]

PLoS One
Shingler L, Tamhane A, Chu CM, Frey JA, Levitan EB, Judd SE, Bullen AL, Siew ED, Bonventre JV, Shlipak MG, Jaeger B, Seegmiller JC, Keister A, Gutierrez OM, Ix JH, Wang HE.   +15 more
europepmc   +1 more source

A Prospective Study of Marsh PK‐PD Model and Schnider PK‐PD Model During Anesthesia Induction for Obese Patients Undergoing Elective Heart Surgery

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT This prospective study compared the Marsh and Schnider pharmacokinetic models for propofol target‐controlled infusion (TCI) during anesthetic induction in obese patients undergoing elective cardiac surgery. A total of 118 patients were randomly assigned to either the Marsh or Schnider group (n = 59 each).
Jianhong Ye, Weina Liang
wiley   +1 more source

Development efficiency and mortality after coronary artery bypass grafting: a national causal inference analysis. [PDF]

J Cardiothorac Surg
Martins GK, Botelho AD, Consoli L, Grillo IT, Passos FS, Treml RE, Caldonazo T.   +6 more
europepmc   +1 more source

Identifying Symptom Clusters Predictive of Acute Myocardial Infarction for Aboriginal and Torres Strait Islander and Non‐Indigenous Australians

Emergency Medicine Australasia, Volume 38, Issue 3, June 2026.
ABSTRACT Objectives This study examines the symptoms experienced by patients investigated for Acute Coronary Syndrome (ACS). It aims to determine whether symptom clusters exist, whether these predict acute myocardial infarction (AMI), and whether symptom patterns differ between Aboriginal and Torres Strait Islander people and non‐Indigenous Australians.
Jaimi Greenslade, William Parsonage, Laura Stephensen, Jeremy Rigney, Katrina Starmer, Gregory Starmer, Virginia Campbell, Emma Hall, Niranjan Gaikwad, Siegfried Perez, Louise Cullen, on behalf of the Legend investigators, Jaimi Greenslade, Louise Cullen, William Parsonage, Laura Stephensen, Robert Bonnin, David Brain, Emily Brownlee, Virginia Campbell, Brooke Charters, Derek Chew, Gemma Figtree, Vanessa Funk, Gavin Fincher, Niranjan Gaikwad, Emma Hall, Christian Hamilton‐Craig, Ellyse McCormick, Steven M McPhail, Siegfried Perez, Jeremy Rigney, Gregory Starmer, Katrina Starmer, Richard Stone   +34 more
wiley   +1 more source

Comparative analysis of quality of life post coronary angioplasty and bypass surgery: A follow-up study on cardiac patients. [PDF]

Medicine (Baltimore)
Shaphe MA, Alshehri MM, Aldhahi MI, Ahmad A, Raheem Khan A, Khan A, Aafreen A, Pandey SK.   +7 more
europepmc   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

To inform or educate the CABG patients [PDF]

The Turkish Journal of Thoracic and Cardiovascular Surgery, 2018
Sahillioglu, Emre, Ulugol, Halim, Toraman, Fevzi   +2 more
openaire   +3 more sources

Sex‐Specific Associations of Inflammatory Biomarkers With All‐Cause and Cardiovascular Mortality Across Glycaemic Status: A Prospective UK Biobank Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4728-4740, June 2026.
ABSTRACT Aims To explore sex‐specific heterogeneity in the prognostic discrimination of inflammatory markers for mortality across different glycaemic states. Methods This prospective cohort study included 450 438 participants from the UK Biobank (median follow‐up: 15.3 years), stratified by sex and glycaemic status.
Yawen Zhang, Menghan Li, Manrong Xu, Yun Shen, Lianxi Li, Gang Hu   +5 more
wiley   +1 more source

Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4975-4990, June 2026.
ABSTRACT Aims To evaluate the association between semaglutide 2.4 mg and major adverse cardiovascular events (MACE) among adults with clinical atherosclerotic cardiovascular disease (ASCVD) and overweight/obesity without diabetes in real‐world clinical practice.
Michael G. Nanna, Carlos Mena‐Hurtado, Victoria Divino, Zhenxiang Zhao, Yan Chen, Joanna Boland, Jinlin Song, Andrea Traina, Kerem Ozer, Filip K. Knop, Kim G. Smolderen   +10 more
wiley   +1 more source

The dynamics of moderate ischaemic mitral regurgitation (IMR) and left ventricular (LV) remodeling after isolated coronary artery bypass grafting (CABG) versus CABG and concomitant mitral valve repair (MVR)

, 2018
Author: Aistė Jasinskaitė Scientific supervisor: prof. habil. dr. J. J. Vaškelytė Title: The dynamics of moderate ischaemic mitral regurgitation (IMR) and left ventricular (LV) remodeling after isolated coronary artery bypass grafting (CABG) versus CABG ...
Jasinskaitė, Aistė
core